期刊文献+

基于PDE-4靶标的桑白皮提取物桑辛素M对小鼠哮喘模型的治疗作用和机制研究 被引量:3

Effect and mechanism of PDE-4 inhibitor moracin M extracted from cortex mori radicis in mice with asthma
原文传递
导出
摘要 目的 研究基于磷酸二酯酶4 (PDE-4)靶标的桑白皮提取物桑辛素 M 对小鼠哮喘模型的治疗作用和机制。方法 建立卵蛋白 (OVA)诱导哮喘小鼠模型,造模期间同时给予桑辛素 M(每天54 7mg/kg)灌胃,连续给药4周。造模结束后检测小鼠吸入乙酰甲胆碱激发后的气道反应性,提取小鼠肺组织总蛋白进行双向电泳,对表达差异显著的蛋白点进行鉴定分析。结果 桑辛素 M可显著降低哮喘小鼠气道高反应性,抑制气道嗜酸粒细胞浸润和气道炎症。蛋白质组学实验显示转胶蛋白-2、胞内氯离子通道蛋白5 (CLIC5)、G (o)蛋白-α亚基、二甲基精氨酸二甲基氨基酸水解酶2(DDAH2)4种蛋白在哮喘小鼠肺组织中表达显著下降,其余18种差异蛋白的表达则显著增加,而药物干预可显著抑制哮喘小鼠相关差异蛋白的表达下降或增加。结论 桑白皮提取物桑辛素 M可能通过改善气道上皮功能、舒张气管平滑肌、提高机体抗氧化能力、抑制炎性细胞浸润、抑制气道组织重塑而发挥抗哮喘作用。 Objective To investigate the therapeutic effect and mechanism of moracin M extracted from Cortex Mori Radicis which based on phosphodiesterase-4 (PDE-4) target in asthma mice. Methods Asthma were induced in mice sensitized and challenged by ovalbumin (OVA), during which moracin M (54.7 mg^1·kg^1·d^1) was orally administered for four weeks. The airway responsiveness of mice after methacholine challenge was measured at the last OVA challenge. Total protein of lung tissue of mice was extracted and analyzed by two-dimensional electrophoresis. The differentially-expressed proteins between normal and asthma groups were further identified. Results Moracin M significantly reduce the airway hyperresponsiveness to methacholine, inhibit the airway eosinophil infiltration and airway inflammation in asthma mice. Proteomics results showed that expressions of transgelin-2, chloride intracellular channel protein 5 (CLICS), G(o) protein a subunit, dimethy larginine dimethy lamino acid hydrolase 2 (DDAH2) were significantly decreased in lung tissue of asthma mice, while levels of other 18 proteins were increased significantly. Moracin M intervention significantly inhibited the increase or decrease of related differential- expressed proteins in asthma mice. Conclusions Moracin M may be effective on inhibiting asthma by enhancing antioxidant capacity, suppressing the inflammatory cell infiltration and inhibiting airway tissue remodeling.
作者 马飞 廖东江 雷玉 何细新 Ma Fei;Liao Dongjiang;Lei Yu;He Xixin(Department of Internal Medicine, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China)
出处 《国际呼吸杂志》 2018年第7期485-489,共5页 International Journal of Respiration
基金 广州市科技计划项目(201607010293)
关键词 桑辛素M 小鼠 哮喘 治疗机制 Moracin M Mouse Asthma Mechanism
  • 相关文献

参考文献8

二级参考文献135

  • 1包爱华,周新.氧化应激及抗氧化治疗与支气管哮喘[J].中华哮喘杂志(电子版),2012,6(5):359-365. 被引量:9
  • 2杨静娴,林原.平滑肌收缩的非钙依赖性调节机制[J].国外医学(生理病理科学与临床分册),2004,24(6):560-563. 被引量:3
  • 3姜代勋,陈武,于同泉,路苹,杨柳,穆祥.中草药对磷酸二酯酶4活性影响的初步研究[J].北京农学院学报,2006,21(1):7-9. 被引量:12
  • 4何军,刘海潮,马业新.非对称二甲基精氨酸促进大鼠主动脉氧化型低密度脂蛋白受体表达[J].中国动脉硬化杂志,2006,14(12):1031-1034. 被引量:4
  • 5Nandeuil A, Kottakis I, Raptis H, et al. Efficacy of the novel very long-acting β2-agonist carmoterol following 7 days once daily dosing: comparison with twice daily formoterol in patient with persistent asthma [J]. Eur Respir J, 2006, 28 (Suppl 50) : $665.
  • 6Nandeuil A, Kottakis I, Raptis H, et al. Safety and tolerability of the novel very long acting β2-agonist carmoterol given as a 2 μg qd dose; 8 days comparison with formoterol and placebo in patients with persistent asthma[J]. Eur Respir J, 2006, 28 (Suppl 50) : S665.
  • 7Beeh KM, Derom E, Kanniess F, et al. Indacaterol, a novel inhaled beta2-agonist, provides sustained 24-h bronchodilation in asthma[J]. Eur Respir J, 2007, 29 (5): 871-878.
  • 8Cerasoli Jr. Developing the ideal inhaled corticosteroid [J]. Chest, 2006, 130(1): S54-S64.
  • 9Chapman KR, Patel P, D'Urzo AD, et al. Maintenance of asthma control by once-daily inhaled ciclesonide in adults with persistent asthma[J]. Allergy, 2005, 60 (3) : 330-337.
  • 10Hansel TT, Biberger C, Engelstatter R. Ciclesonide 80 μg or 320μg once daily achieves lung function improvement comparable with budesonide 200 μg twice daily in patients with persistent asthma[J]. Thorax, 2004, 59 (suppl) : 12.

共引文献134

同被引文献37

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部